Treatment of urinary incontinence in women with chronic obstructive pulmonary disease-a randomised controlled study

Stacey Haukeland-Parker, Bente Frisk, Martijn A Spruit, Signe Nilssen Stafne, Hege Hølmo Johannessen, Stacey Haukeland-Parker, Bente Frisk, Martijn A Spruit, Signe Nilssen Stafne, Hege Hølmo Johannessen

Abstract

Background: Little is known regarding treatment of urinary incontinence (UI) in women with chronic obstructive pulmonary disease (COPD). The aim of the study was to explore the efficacy of pelvic floor muscle training (PFMT) or cough-suppression techniques (CST) on UI in women with COPD.

Methods: A three-armed, two-centred, single-blinded, randomised controlled study was performed. Subjects were randomised to (a) PFMT for 16 weeks, (b) 2-3 educational sessions in CST, or (c) written information only. All participants completed questionnaires about UI, cough symptoms, and health status and underwent clinical examinations to evaluate the strength of the pelvic floor muscles and exercise capacity. Daily physical activity levels were measured using an activity monitor and lung function with spirometry. With a significance level of 5% and an 80% chance of detecting a significant difference between groups of 2.5 points on the ICIQ UI SF score, our sample size calculation showed that a total of 78 women, 26 in each group, was required to complete the study.

Results: During the period 2016 to 2018, 95 women were invited to the study. A total of 42 were recruited, three were excluded and 10 (24%) dropped out during the follow-up period. Mean ICIQ-UI SF total baseline score was 9.6 (range: 1-17) and 7.0 (range: 0-16) at follow-up. Changes in subjective UI as measured with the ICIQ-UI SF questionnaire were seen in the PFMT group and control group, but not in the CST group.

Conclusion: Due to the low number of available participants and recruitment difficulties including practical issues such as travel distance, lack of interest, poor state of health, and high number of comorbidities, our results are inconclusive. However, reduced subjective UI was observed in the PFMT and control groups with a trend towards best effect in the PFMT group. Screening for UI is advisable in all women with COPD to be able to identify and treat these women to reduce symptom burden and improve quality of life. Future studies should focus on barriers to recruitment as well as randomised controlled studies with larger sample sizes.

Trial registration: ClinicalTrials.gov NCT02614105. 25th November 2015.

Keywords: Chronic obstructive pulmonary disease; Cough-suppression therapy; Pelvic floor muscle training; Urinary incontinence.

Conflict of interest statement

The authors declare that they have no conflict of interest.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Flow chart of the recruitment and inclusion process through each stage of the randomised controlled trial
Fig. 2
Fig. 2
Change in ICIQ-UI SF scores from baseline to post-intervention (n=29)

References

    1. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol. 2000;53(11):1150–1157. doi: 10.1016/S0895-4356(00)00232-8.
    1. Chiarelli P, Brown WJ. Leaking urine in Australian women: prevalence and associated conditions. Women Health. 1999;29(1):1–13. doi: 10.1300/J013v29n01_01.
    1. Woodley SJ, Boyle R, Cody JD, Morkved S, Hay-Smith EJC. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev. 2017;12:Cd007471.
    1. Dumoulin C, Cacciari LP, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10).
    1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN, International Urogynecological Association. International Continence Society An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. doi: 10.1002/nau.20798.
    1. Battaglia S, Benfante A, Principe S, Basile L, Scichilone N. Urinary incontinence in chronic obstructive pulmonary disease: a common co-morbidity or a typical adverse effect? Drugs Aging. 2019;36(9):799–806. doi: 10.1007/s40266-019-00687-4.
    1. Newman DK. In men and women with COPD the presence of urinary incontinence is associated with poorer quality of life. Evid Based Nurs. 2014;17(1):22–23. doi: 10.1136/eb-2013-101290.
    1. Global Strategy for the Diagnois . Management, and prevention of chronic obstructive pulmonary disease. 2020.
    1. Hrisanfow E, Hagglund D. The prevalence of urinary incontinence among women and men with chronic obstructive pulmonary disease in Sweden. J Clin Nurs. 2011;20(13-14):1895–1905. doi: 10.1111/j.1365-2702.2010.03660.x.
    1. Aigon A, Billecocq S. Prevalence and impact on quality of life of urinary incontinence in an adult population with chronic obstructive pulmonary diseases, literature review. Prog Urol. 2018;28(17):962–972. doi: 10.1016/j.purol.2018.08.016.
    1. Masror-Roudsary D, Fadaee Aghdam N, Rafii F, Baha R, Khajeh M, Mardani A. The relationship between experienced respiratory symptoms and health-related quality of life in the elderly with chronic obstructive pulmonary disease. Crit Care Res Pract. 2021;2021:5564275–5564277. doi: 10.1155/2021/5564275.
    1. Witkoś J, Hartman-Petrycka M. Do future healthcare professionals have adequate knowledge about risk factors for stress urinary incontinence in women? BMC Womens Health. 2020;20(1):254. doi: 10.1186/s12905-020-01124-0.
    1. Writers AM. Manage urinary incontinence in COPD depending on whether it is stress, urge or mixed. Drugs Ther Perspect. 2020;36(6):230–233. doi: 10.1007/s40267-020-00735-9.
    1. Hrisanfow E, Hagglund D. Impact of cough and urinary incontinence on quality of life in women and men with chronic obstructive pulmonary disease. J Clin Nurs. 2013;22(1-2):97–105. doi: 10.1111/j.1365-2702.2012.04143.x.
    1. Debus G, Kastner R. Psychosomatic aspects of urinary incontinence in women. Geburtshilfe und Frauenheilkunde. 2015;75(2):165–169. doi: 10.1055/s-0034-1396257.
    1. Kwak Y, Kwon H, Kim Y. Health-related quality of life and mental health in older women with urinary incontinence. Aging Ment Health. 2015;20(7):1–8. doi: 10.1080/13607863.2015.1033682.
    1. Senra C, Pereira MG. Quality of life in women with urinary incontinence. Revista da Associacao Medica Brasileira (1992) 2015;61(2):178–183. doi: 10.1590/1806-9282.61.02.178.
    1. Nygaard I, Girts T, Fultz NH, Kinchen K, Pohl G, Sternfeld B. Is urinary incontinence a barrier to exercise in women? Obstet Gynecol. 2005;106(2):307–314. doi: 10.1097/01.AOG.0000168455.39156.0f.
    1. Troosters T, Demeyer H. Physical inactivity as a missing link in understanding the progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(3):267–269. doi: 10.1164/rccm.201506-1123ED.
    1. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, Benzo R, Andre D, Weisman I, Decramer M. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104(7):1005–1011. doi: 10.1016/j.rmed.2010.01.012.
    1. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, Vaes AW, Puhan MA, Jehn M, Polkey MI, Vogiatzis I, Clini EM, Toth M, Gimeno-Santos E, Waschki B, Esteban C, Hayot M, Casaburi R, Porszasz J, McAuley E, Singh SJ, Langer D, Wouters EFM, Magnussen H, Spruit MA. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi: 10.1183/09031936.00046814.
    1. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi: 10.1378/chest.10-2521.
    1. Button BM, Holland AE, Sherburn MS, Chase J, Wilson JW, Burge AT. Prevalence, impact and specialised treatment of urinary incontinence in women with chronic lung disease. Physiotherapy. 2019;105(1):114–119. doi: 10.1016/j.physio.2018.07.006.
    1. Chamberlain S, Garrod R, Birring SS. Cough suppression therapy: does it work? Pulm Pharmacol Ther. 2013;26(5):524–527. doi: 10.1016/j.pupt.2013.03.012.
    1. Slovarp LJ, Jetté ME, Gillespie AI, Reynolds JE, Barkmeier-Kraemer JM. Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy. Lung. 2021;199(3):263–271. doi: 10.1007/s00408-021-00442-w.
    1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3):1700214. doi: 10.1183/13993003.00214-2017.
    1. Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, Fleck SJ, Franklin B, Fry AC, Hoffman JR, Newton RU, Potteiger J, Stone MH, Ratamess NA, Triplett-McBride T, American College of Sports Medicine American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2002;34(2):364–380. doi: 10.1097/00005768-200202000-00027.
    1. Bø K. Physiotherapy management of urinary incontinence in females. J Physiother. 2020;66(3):147–154. doi: 10.1016/j.jphys.2020.06.011.
    1. Morkved S, Bo K, Fjortoft T. Effect of adding biofeedback to pelvic floor muscle training to treat urodynamic stress incontinence. Obstet Gynecol. 2002;100(4):730–739. doi: 10.1016/s0029-7844(02)02160-9.
    1. Bo K. Pelvic floor muscle exercise and urinary incontinence--train yourself continent! Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2000;120(29):3583–3589.
    1. Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–330. doi: 10.1002/nau.20041.
    1. Sirls LT, Tennstedt S, Brubaker L, Kim HY, Nygaard I, Rahn DD, Shepherd J, Richter HE. The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence. Neurourol Urodyn. 2015;34(2):183–187. doi: 10.1002/nau.22533.
    1. Vooijs M, Alpay LL, Snoeck-Stroband JB, Beerthuizen T, Siemonsma PC, Abbink JJ, Sont JK, Rövekamp TA. Validity and usability of low-cost accelerometers for internet-based self-monitoring of physical activity in patients with chronic obstructive pulmonary disease. Interact J Med Res. 2014;3(4):e14. doi: 10.2196/ijmr.3056.
    1. Farooqi N, Slinde F, Haglin L, Sandstrom T. Validation of SenseWear Armband and ActiHeart monitors for assessments of daily energy expenditure in free-living women with chronic obstructive pulmonary disease. Physiol Rep. 2013;1(6):e00150. doi: 10.1002/phy2.150.
    1. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–1478. doi: 10.1183/09031936.00150414.
    1. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi: 10.1183/09031936.00150314.
    1. Berkhof FF, Boom LN, ten Hertog NE, Uil SM, Kerstjens HA, van den Berg JW. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes. 2012;10(1):4. doi: 10.1186/1477-7525-10-4.
    1. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) Thorax. 2003;58(4):339–343. doi: 10.1136/thorax.58.4.339.
    1. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. Copd. 2012;9(1):12–15. doi: 10.3109/15412555.2011.630248.
    1. Messelink B, Benson T, Berghmans B, Bo K, Corcos J, Fowler C, et al. Standardization of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn. 2005;24(4):374–380. doi: 10.1002/nau.20144.
    1. Laszlo G. European standards for lung function testing: 1993 update. Thorax. 1993;48(9):873–876. doi: 10.1136/thx.48.9.873.
    1. Paiva LL, Ferla L, Darski C, Catarino BM, Ramos JGL. Pelvic floor muscle training in groups versus individual or home treatment of women with urinary incontinence: systematic review and meta-analysis. Intl Urogynecol J. 2017;28(3):351–359. doi: 10.1007/s00192-016-3133-2.
    1. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(2):629–634. doi: 10.1164/ajrccm.158.2.9711023.
    1. Miller JM, Perucchini D, Carchidi LT, DeLancey JO, Ashton-Miller J. Pelvic floor muscle contraction during a cough and decreased vesical neck mobility. Obstet Gynecol. 2001;97(2):255–260. doi: 10.1016/s0029-7844(00)01132-7.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit